These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32825842)

  • 1. Increased levels of Stress-inducible phosphoprotein-1 accelerates amyloid-β deposition in a mouse model of Alzheimer's disease.
    Lackie RE; Marques-Lopes J; Ostapchenko VG; Good S; Choy WY; van Oosten-Hawle P; Pasternak SH; Prado VF; Prado MAM
    Acta Neuropathol Commun; 2020 Aug; 8(1):143. PubMed ID: 32825842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases.
    Lackie RE; Maciejewski A; Ostapchenko VG; Marques-Lopes J; Choy WY; Duennwald ML; Prado VF; Prado MAM
    Front Neurosci; 2017; 11():254. PubMed ID: 28559789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prion protein ligand, stress-inducible phosphoprotein 1, regulates amyloid-β oligomer toxicity.
    Ostapchenko VG; Beraldo FH; Mohammad AH; Xie YF; Hirata PH; Magalhaes AC; Lamour G; Li H; Maciejewski A; Belrose JC; Teixeira BL; Fahnestock M; Ferreira ST; Cashman NR; Hajj GN; Jackson MF; Choy WY; MacDonald JF; Martins VR; Prado VF; Prado MA
    J Neurosci; 2013 Oct; 33(42):16552-64. PubMed ID: 24133259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease.
    Sadleir KR; Eimer WA; Kaufman RJ; Osten P; Vassar R
    PLoS One; 2014; 9(7):e101643. PubMed ID: 24992504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity.
    Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; Kusters B; Maat-Schieman ML; de Waal RM; Verbeek MM
    Acta Neuropathol; 2006 Feb; 111(2):139-49. PubMed ID: 16485107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo.
    Lackie RE; de Miranda AS; Lim MP; Novikov V; Madrer N; Karunatilleke NC; Rutledge BS; Tullo S; Brickenden A; Maitland MER; Greenberg D; Gallino D; Luo W; Attaran A; Shlaifer I; Del Cid Pellitero E; Schild-Poulter C; Durcan TM; Fon EA; Duennwald M; Beraldo FH; Chakravarty MM; Bussey TJ; Saksida LM; Soreq H; Choy WY; Prado VF; Prado MAM
    Acta Neuropathol; 2022 Nov; 144(5):881-910. PubMed ID: 36121476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
    Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
    J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular prion protein acts as mediator of amyloid beta uptake by caveolin-1 causing cellular dysfunctions in vitro and in vivo.
    da Silva Correia A; Schmitz M; Fischer AL; da Silva Correia S; Simonetti FL; Saher G; Goya-Maldonado R; Arora AS; Fischer A; Outeiro TF; Zerr I
    Alzheimers Dement; 2024 Oct; 20(10):6776-6792. PubMed ID: 39212313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer's Disease.
    Maiti P; Manna J; Burch ZN; Flaherty DB; Larkin JD; Dunbar GL
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of hippocampal neuronal resilience during aging by the Hsp70/Hsp90 co-chaperone STI1.
    Lackie RE; Razzaq AR; Farhan SMK; Qiu LR; Moshitzky G; Beraldo FH; Lopes MH; Maciejewski A; Gros R; Fan J; Choy WY; Greenberg DS; Martins VR; Duennwald ML; Lerch JP; Soreq H; Prado VF; Prado MAM
    J Neurochem; 2020 Jun; 153(6):727-758. PubMed ID: 31562773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Dynamics of β-Amyloid Proteoforms Accumulation in the Brain of a 5xFAD Mouse Model of Alzheimer's Disease.
    Bugrova AE; Strelnikova PA; Indeykina MI; Kononikhin AS; Zakharova NV; Brzhozovskiy AG; Barykin EP; Pekov SI; Gavrish MS; Babaev AA; Kosyreva AM; Morozova AY; Degterev DA; Mitkevich VA; Popov IA; Makarov AA; Nikolaev EN
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of exogenous acetylcholinesterase and butyrylcholinesterase with amyloid-β plaques in human brain tissue.
    Reid GA; Darvesh S
    Chem Biol Interact; 2024 May; 395():111012. PubMed ID: 38648920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of Exogenous Butyrylcholinesterase with β-Amyloid Plaques in 5XFAD/Butyrylcholinesterase-Knockout Mouse Brain.
    Reid GA; Darvesh S
    Curr Alzheimer Res; 2021; 18(6):470-481. PubMed ID: 34455970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
    Devi L; Ohno M
    Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.